Trial intelligence / Profile preview

Intravenous Lidocaine for Post-operative Pain in Colorectal Patients

NCT01836614Phase 2Withdrawn

Sponsor
Cincinnati Children's Hospital Medical Center
Start
Jan 2015
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, postoperative ileus (POI), sponsored by Cincinnati Children's Hospital Medical Center. Planned start Jan 2015; status: withdrawn.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative painpostoperative ileus (POI)

Beyond the preview

Go deeper on NCT01836614.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01836614.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call